The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases
The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases
Podcast Description
AD/PD™ is the leading international platform dedicated to exploring the latest breakthroughs and treatments in Alzheimer's, Parkinson’s, and related neurodegenerative diseases. The "AD/PD™ Session Spotlight" series is an AI-powered podcast that brings you key insights from the AD/PD™ Conference, with expert presentations and research discussions transformed into concise, easy-to-digest episodes.
Join us as we uncover the latest innovations, explore groundbreaking research, and discuss the future of neurodegenerative disease treatments and therapies.
Podcast Insights
Content Themes
The podcast centers on neurodegenerative diseases, particularly Alzheimer's and Parkinson's, covering areas like regulatory philosophies, approval processes, biomarker developments, and clinical implications. Recent episodes discuss topics such as varying regulatory approaches to drug approvals across different regions and the role of biomarkers in treatment selection, reflecting the latest research presented at the AD/PD™ 2025 Conference.

AD/PD™ is the leading international platform dedicated to exploring the latest breakthroughs and treatments in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases. The “AD/PD™ Session Spotlight” series is an AI-powered podcast that brings you key insights from the AD/PD™ Conference, with expert presentations and research discussions transformed into concise, easy-to-digest episodes.
Join us as we uncover the latest innovations, explore groundbreaking research, and discuss the future of neurodegenerative disease treatments and therapies.
In this episode, Prof. Craig Ritchie, Professor of Brain Healthand Neurogenetic Medicine at the University of St Andrews, discusses theevolving role of blood-based biomarkers, particularly p-tau217, in thediagnosis and management of Alzheimer's disease. He explores their clinicalutility, limitations, and potential integration into primary care pathways,highlighting how these advances could enable earlier detection, more accuratediagnosis, and timely access to disease-modifying treatments.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.